市场调查报告书
商品编码
1376876
体外心臟去颤器市场规模(依产品)(手动体外心臟去颤器、自动体外心臟去颤器、穿戴式体外心臟復律去颤器)、最终用途和预测,2023 - 2032 年External Defibrillators Market Size By Product (Manual External Defibrillator, Automated External Defibrillator, Wearable External Cardioverter Defibrillator), By End-use, & Forecast, 2023 - 2032 |
由于紧急医疗服务和医疗保健设施越来越重视早期除颤,体外去颤器市场规模预计从 2023 年到 2032 年将以 7.4% 的复合年增长率扩大。
人们越来越关注缩短反应时间、加强院前护理和改善患者治疗效果,这使得在紧急医疗环境中便携式和用户友好型除颤设备的采用激增。此外,除颤器技术的不断进步,包括开发具有先进功能和智慧功能的自动体外心臟去颤器(AED),以提高设备可用性和功效,将有助于市场成长。例如,2023 年 1 月,Avive Solutions 的 Avive AEDTM 获得了美国 FDA 的上市前批准,这是其创新的 AED,具有蜂窝、WiFi、GPS 和蓝牙连接等先进功能。
体外除颤器产业分为产品、最终用途和地区。
根据产品来看,预计穿戴式体外心臟復律去颤器市场将在 2023 年至 2032 年间获得巨大的吸引力,因为它们能够提供持续的心臟监测和及时的去颤治疗。穿戴式体外心臟復律去颤器的非侵入性和可穿戴式设计,加上便携性和使用者友善操作,正在推动其在临床和非临床环境中的应用。
根据最终用途,院前护理领域的体外去颤器产业可能会在 2023 年至 2032 年期间出现可观的成长。院前环境(包括救护车、紧急医疗服务和急救单位)对快速除颤的需求不断增长,这使得对便携式和用户友好型体外除颤器的需求激增。此外,人们越来越关注改善患者治疗结果、缩短反应时间和加强紧急医疗护理,这进一步促进了产品在院前心臟护理和管理中的采用。
预计到 2032 年,亚太地区体外除颤器产业将出现强劲成长。这是由于心血管疾病盛行率不断上升、老年人口基数不断扩大以及该地区心臟急救管理意识不断提高所推动的。此外,支持性监管政策、政府提高公众对心臟骤停管理认识的倡议以及在公共场所安装除颤器的强制要求正在推动区域市场的成长。举个例子,2023年6月,印度北方邦政府宣布计划在所有商场和政府大楼安装AED,以便在心臟骤停的情况下为患者提供必要的急救。
External Defibrillators Market size is set to expand at 7.4% CAGR from 2023-2032 driven by the increasing emphasis on early defibrillation in emergency medical services and healthcare facilities.
The growing attention to reducing response times, enhancing prehospital care, and improving patient outcomes is surging the adoption of portable and user-friendly defibrillation devices in emergency medical settings. Furthermore, the ongoing advancements in defibrillator technology, including the development of automated external defibrillators (AEDs) with advanced features and smart functionalities for improved device usability and efficacy will contribute to market growth. For instance, in January 2023, Avive Solutions received pre-market approval from the U.S. FDA for Avive AEDTM, its innovative AED with advanced features, such as cellular, WiFi, GPS, and Bluetooth connection.
The external defibrillators industry is segmented into product, end-use, and region.
Based on product, the wearable external cardioverter defibrillators market is foreseen to gain significant traction between 2023 and 2032 attributed to their ability to provide continuous cardiac monitoring and prompt defibrillation therapy. The non-invasive and wearable designs coupled with the portability and user-friendly operations offered by wearable external cardioverter defibrillators is spurring their application in clinical and non-clinical settings.
Based on end-use, the external defibrillators industry from the prehospital care segment is likely to depict considerable growth from 2023-2032. The thriving need for prompt defibrillation in prehospital settings, including ambulances, emergency medical services, and first responder units is surging the demand for portable and user-friendly external defibrillators. Additionally, the increasing focus on improving patient outcomes, reducing response times, and enhancing emergency medical care is further contributing to the increasing product adoption in prehospital cardiac care and management.
Asia Pacific external defibrillators industry is estimated to witness robust growth through 2032. This is driven by the increasing prevalence of cardiovascular diseases, expanding geriatric population base, and the rising awareness of cardiac emergency management in the region. Moreover, the supportive regulatory policies, the government initiatives for promoting public awareness about sudden cardiac arrest management, and mandates for defibrillator installation in public spaces is driving the regional market growth. To cite an instance, in June 2023, the government of Uttar Pradesh in India announced plans to install AEDs at all malls, and government buildings to provide necessary first aid to patients in case of cardiac arrest.